From June 2027, European cosmetics cannot contain more than 0.1% of D5 or D6 in any product category, leave-on formats included. That single threshold is rewriting formulation strategy across beauty, and it lands squarely in the dermatology-adjacent space where texture claims meet clinical performance.

Silicones earned their place honestly. They make creams glide, primers blur, hair serums shine, sunscreens spread evenly, and colour cosmetics feel lighter than their pigment load suggests. For years, they were the quiet performance engine behind what the industry calls premium feel. Nobody disputed the sensory math.

What does the 0.1% limit actually change?

Not everything disappears. The restriction targets two cyclic siloxanes, D5 and D6 — not the entire silicone family. But it changes the risk calculation for every brand selling in Europe.

Product developers now face a fork. They can reformulate reactively, ingredient by ingredient, each time a regulator tightens a threshold. Or they can proactively build new sensory systems that are less exposed to future scrutiny. The second path costs more upfront. It also buys regulatory resilience, which is becoming a formulation asset in its own right.

The new question for brands is no longer whether silicones work. They do. The question is whether the next generation of beauty can hit the same sensory standard with ingredients that better match current expectations on sustainability, transparency, and regulatory survival.

That is why natural silicone alternatives are moving from niche claim to strategic formulation priority. Not marketing. Pipeline.

The commercial signal behind the regulation

The shift is not only regulatory. It is commercial, and the numbers are large.

The global natural personal care ingredients market was valued at US$5.3bn in 2023. MarketsandMarkets projects it will reach $7.9bn by 2028, growing at 8.3% CAGR. A $2.6bn expansion in five years does not happen on the strength of consumer sentiment alone. It happens when regulation, retailer standards, and procurement calendars all point the same direction.

For practitioners and clinic-adjacent brands, that growth rate signals supplier investment. Expect more natural sensory modifiers reaching formulation benches, faster, with better documentation than the first generation of silicone replacements carried.

Why dermatology should care about texture engineering

Silicones were never merely cosmetic. They drove compliance in leave-on therapeutics, sunscreen adherence, and barrier formulations. Any ingredient class that quietly underpinned spreadability and wear now faces substitution at scale, and substitution is where sensory regression — and patient complaints about feel — typically creeps in.

The formulation race is therefore about equivalence, not replacement. Which natural alternative replicates the slip of dimethicone? Which one keeps a sunscreen from pilling under makeup? Those are the questions suppliers are now being paid to answer.

A date for the calendar

The industry will take stock of the winners in this transition at the 25th anniversary of the Pure Beauty Awards, held on 15 October 2026 at the Grosvenor House Hotel in London. By then, most European-relevant reformulations for the D5/D6 deadline will already be locked, which makes the 2026 entries an early read on which natural sensory systems are actually delivering.

The bottom line

June 2027 is not far away in formulation terms. Brands that treat the 0.1% threshold as a design brief rather than a compliance chore will define the next sensory standard. Watch the natural ingredients pipeline, and watch which entries at next year's awards carry the new systems — because the market math, an 8.3% annual climb toward $7.9bn, says the alternatives have already outgrown the niche.